These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8117658)
21. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme. El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717 [TBL] [Abstract][Full Text] [Related]
22. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications. Wilson DK; Bohren KM; Gabbay KH; Quiocho FA Science; 1992 Jul; 257(5066):81-4. PubMed ID: 1621098 [TBL] [Abstract][Full Text] [Related]
23. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase. Nakano T; Petrash JM Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524 [TBL] [Abstract][Full Text] [Related]
24. Catalytic mechanism of aldose reductase studied by the combined potentials of quantum mechanics and molecular mechanics. Lee YS; Hodoscek M; Brooks BR; Kador PF Biophys Chem; 1998 Mar; 70(3):203-16. PubMed ID: 9546197 [TBL] [Abstract][Full Text] [Related]
25. Structure of a glutathione conjugate bound to the active site of aldose reductase. Singh R; White MA; Ramana KV; Petrash JM; Watowich SJ; Bhatnagar A; Srivastava SK Proteins; 2006 Jul; 64(1):101-10. PubMed ID: 16639747 [TBL] [Abstract][Full Text] [Related]
26. The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48. Ruiz F; Hazemann I; Mitschler A; Joachimiak A; Schneider T; Karplus M; Podjarny A Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1347-54. PubMed ID: 15272156 [TBL] [Abstract][Full Text] [Related]
27. The C-terminal loop of aldehyde reductase determines the substrate and inhibitor specificity. Barski OA; Gabbay KH; Bohren KM Biochemistry; 1996 Nov; 35(45):14276-80. PubMed ID: 8916913 [TBL] [Abstract][Full Text] [Related]
28. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor. El-Kabbani O; Darmanin C; Oka M; Schulze-Briese C; Tomizaki T; Hazemann I; Mitschler A; Podjarny A J Med Chem; 2004 Aug; 47(18):4530-7. PubMed ID: 15317464 [TBL] [Abstract][Full Text] [Related]
29. Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors. El-Kabbani O; Darmanin C; Schneider TR; Hazemann I; Ruiz F; Oka M; Joachimiak A; Schulze-Briese C; Tomizaki T; Mitschler A; Podjarny A Proteins; 2004 Jun; 55(4):805-13. PubMed ID: 15146479 [TBL] [Abstract][Full Text] [Related]
30. Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex. Sugiyama K; Chen Z; Lee YS; Kador PF Biochem Pharmacol; 2000 Feb; 59(4):329-36. PubMed ID: 10644040 [TBL] [Abstract][Full Text] [Related]
31. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera. Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501 [TBL] [Abstract][Full Text] [Related]
32. Active site modification of aldose reductase by nitric oxide donors. Chandra A; Srivastava S; Petrash JM; Bhatnagar A; Srivastava SK Biochim Biophys Acta; 1997 Sep; 1341(2):217-22. PubMed ID: 9357961 [TBL] [Abstract][Full Text] [Related]
33. Structural and kinetic determinants of aldehyde reduction by aldose reductase. Srivastava S; Watowich SJ; Petrash JM; Srivastava SK; Bhatnagar A Biochemistry; 1999 Jan; 38(1):42-54. PubMed ID: 9890881 [TBL] [Abstract][Full Text] [Related]
34. Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex. el-Kabbani O; Carper DA; McGowan MH; Devedjiev Y; Rees-Milton KJ; Flynn TG Proteins; 1997 Oct; 29(2):186-92. PubMed ID: 9329083 [TBL] [Abstract][Full Text] [Related]
35. Crystal structure of CHO reductase, a member of the aldo-keto reductase superfamily. Ye Q; Hyndman D; Li X; Flynn TG; Jia Z Proteins; 2000 Jan; 38(1):41-8. PubMed ID: 10651037 [TBL] [Abstract][Full Text] [Related]
36. Modelling the catalytic reaction in human aldose reductase. VĂ¡rnai P; Richards WG; Lyne PD Proteins; 1999 Nov; 37(2):218-27. PubMed ID: 10584067 [TBL] [Abstract][Full Text] [Related]
37. Mechanistic basis for nonlinear kinetics of aldehyde reduction catalyzed by aldose reductase. Grimshaw CE; Shahbaz M; Putney CG Biochemistry; 1990 Oct; 29(42):9947-55. PubMed ID: 2125486 [TBL] [Abstract][Full Text] [Related]
38. Identification of an aldose reductase inhibitor site by affinity labeling. Kador PF; Lee YS; Rodriguez L; Sato S; Bartoszko-Malik A; Abdel-Ghany YS; Miller DD Bioorg Med Chem; 1995 Oct; 3(10):1313-24. PubMed ID: 8564397 [TBL] [Abstract][Full Text] [Related]
39. Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities. Rees-Milton KJ; Jia Z; Green NC; Bhatia M; El-Kabbani O; Flynn TG Arch Biochem Biophys; 1998 Jul; 355(2):137-44. PubMed ID: 9675019 [TBL] [Abstract][Full Text] [Related]
40. Studies on pig aldose reductase. Identification of an essential arginine in the primary and tertiary structure of the enzyme. Kubiseski TJ; Green NC; Borhani DW; Flynn TG J Biol Chem; 1994 Jan; 269(3):2183-8. PubMed ID: 8294474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]